Advances in mass spectrometry and chemical probe design have facilitated the development of more sensitive redox proteomics methods, such as the NEM-biotin switch assay or the Gsp-biotin assay to study targets for protein S -glutathionylation at a global scale (Lind et al., 2002
solvent B was 0.01% HCOOH in MeCN
T., Mikhaleva, I
Cagrilintide is developed by Novo Nordisk, the same company behind semaglutide (Ozempic/Wegovy) and the CagriSema combination
For a deeper look at how a medical clinic frames peptide categories, risks, and patient selection, see our companion guide on how a medical clinic reviews safety before prescribing a peptide
Hur SE, Lee JY, Moon HS, Chung HW (2006) Angiopoietin-1, angiopoietin-2 and Tie-2 expression in eutopic endometrium in advanced endometriosis